SUSQUEHANNA INTERNATIONAL GROUP, LLP
Position in PYXS — Pyxis Oncology, Inc.
CIK 1446194
BALA CYNWYD, PA
Position in PYXS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$60,153
-$64,523 QoQ
Shares Held
41,201
-62.0% QoQ
Ownership
0.065%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 78 holders
Holding Since
Jun 2022
13 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PYXS Over Time
Shares Held
Position Value (USD)
Derivatives in PYXS
reported options exposure · as of Mar 31, 2026CallValue
$61,758
CallShares
42,300
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,159,899,084 across 353 Biotechnology names. PYXS ranks #322 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CYTK |
Cytokinetics Inc
|
898,951 | $59,249,860 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
174,268 | $57,660,053 | |
| 3 | AGIO |
Agios Pharmaceuticals, Inc.
|
1,344,953 | $45,499,759 | |
| 4 | ABVX |
Abivax S.A.
|
381,282 | $42,455,750 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
398,943 | $29,625,507 | |
| 6 | INSM |
INSMED Inc
|
173,630 | $28,391,977 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
593,406 | $28,228,323 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
521,571 | $27,497,223 |
All Filings in PYXS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $60,153 | 41,201 | Shares | Other | 2026-05-15 | |
| 2026-03-31 | $61,758 | 42,300 | Call | Other | 2026-05-15 | |
| 2025-12-31 | $207,345 | 180,300 | Call | Other | 2026-02-17 | |
| 2025-12-31 | $124,676 | 108,414 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $47,730 | 21,500 | Call | Other | 2025-11-14 | |
| 2025-09-30 | $305,318 | 137,531 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $125,794 | 114,359 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $63,590 | 64,888 | Shares | Other | 2025-05-14 | |
| 2024-12-31 | $106,041 | 67,975 | Shares | Other | 2025-02-14 | |
| 2024-12-31 | $1,298,232 | 832,200 | Call | Other | 2025-02-14 | |
| 2024-09-30 | $314,952 | 85,818 | Shares | Defined | 2024-11-14 | |
| 2024-09-30 | $87,346 | 23,800 | Call | Defined | 2024-11-14 | |
| 2024-09-30 | $43,673 | 11,900 | Put | Defined | 2024-11-14 | |
| 2024-06-30 | $382,950 | 115,695 | Shares | Defined | 2024-08-15 | |
| 2024-06-30 | $74,144 | 22,400 | Call | Defined | 2024-08-15 | |
| 2024-03-31 | $295,860 | 69,451 | Shares | Defined | 2024-05-07 | |
| 2024-03-31 | $148,674 | 34,900 | Call | Defined | 2024-05-07 | |
| 2023-12-31 | $18,900 | 10,500 | Call | Defined | 2024-02-14 | |
| 2023-12-31 | $21,281 | 11,823 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $64,779 | 32,553 | Shares | Defined | 2023-11-14 | |
| 2023-09-30 | $46,964 | 23,600 | Call | Defined | 2023-11-14 | |
| 2023-06-30 | $70,144 | 27,400 | Call | Defined | 2023-08-11 | |
| 2023-06-30 | $111,627 | 43,605 | Shares | Defined | 2023-08-11 | |
| 2022-06-30 | $34,429 | 14,466 | Shares | Defined | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||